These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32423955)
1. Reduced Susceptibility to Carbapenems in a Klebsiella pneumoniae Clinical Isolate Producing SCO-1 and CTX-M-15 β-Lactamases Together with OmpK35 and OmpK36 Porin Deficiency. Venditti C; Butera O; Proia A; Rigacci L; Mariani B; Parisi G; Messina F; Capone A; Nisii C; Di Caro A Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423955 [No Abstract] [Full Text] [Related]
2. Role of association of OmpK35 and OmpK36 alteration and bla Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592 [TBL] [Abstract][Full Text] [Related]
3. Mutation of Dulyayangkul P; Wan Nur Ismah WAK; Douglas EJA; Avison MB Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32312773 [TBL] [Abstract][Full Text] [Related]
4. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases. Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684 [TBL] [Abstract][Full Text] [Related]
5. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency. Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170 [TBL] [Abstract][Full Text] [Related]
6. The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt. Wassef M; Abdelhaleim M; AbdulRahman E; Ghaith D Microb Drug Resist; 2015 Dec; 21(6):577-80. PubMed ID: 25945596 [TBL] [Abstract][Full Text] [Related]
7. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae. García-Sureda L; Doménech-Sánchez A; Barbier M; Juan C; Gascó J; Albertí S Antimicrob Agents Chemother; 2011 Oct; 55(10):4742-7. PubMed ID: 21807980 [TBL] [Abstract][Full Text] [Related]
8. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia. Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the Genetic Background of KPC-2-Producing Wu LT; Guo MK; Ke SC; Lin YP; Pang YC; Nguyen HV; Chen CM Microb Drug Resist; 2020 Sep; 26(9):1050-1057. PubMed ID: 32283046 [TBL] [Abstract][Full Text] [Related]
10. Carbapenem Resistance Caused by High-Level Expression of OXA-663 β-Lactamase in an OmpK36-Deficient Klebsiella pneumoniae Clinical Isolate. Ma P; Laibinis HH; Ernst CM; Hung DT Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126962 [TBL] [Abstract][Full Text] [Related]
11. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems. Hong JH; Clancy CJ; Cheng S; Shields RK; Chen L; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476 [TBL] [Abstract][Full Text] [Related]
12. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant. Poulou A; Voulgari E; Vrioni G; Koumaki V; Xidopoulos G; Chatzipantazi V; Markou F; Tsakris A J Clin Microbiol; 2013 Oct; 51(10):3176-82. PubMed ID: 23850951 [TBL] [Abstract][Full Text] [Related]
13. Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae. Zhang Y; Jiang X; Wang Y; Li G; Tian Y; Liu H; Ai F; Ma Y; Wang B; Ruan F; Rajakumar K Antimicrob Agents Chemother; 2014; 58(2):1214-7. PubMed ID: 24277031 [TBL] [Abstract][Full Text] [Related]
14. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases. Joshi P; Shrivastava R; Bhagwat S; Patel M Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307 [TBL] [Abstract][Full Text] [Related]
15. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. Landman D; Bratu S; Quale J J Med Microbiol; 2009 Oct; 58(Pt 10):1303-1308. PubMed ID: 19556371 [TBL] [Abstract][Full Text] [Related]
16. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production. Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234 [TBL] [Abstract][Full Text] [Related]
17. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae. Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T mBio; 2020 Apr; 11(2):. PubMed ID: 32291303 [TBL] [Abstract][Full Text] [Related]
19. Investigation on the mechanisms of carbapenem resistance among the non-carbapenemase-producing carbapenem-resistant Lee YQ; Sri La Sri Ponnampalavanar S; Wong JH; Kong ZX; Ngoi ST; Karunakaran R; Lau MY; Abdul Jabar K; Teh CSJ Front Cell Infect Microbiol; 2024; 14():1464816. PubMed ID: 39359938 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea. Kim SY; Shin J; Shin SY; Ko KS Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]